Nueterra Capital’s Post

View organization page for Nueterra Capital, graphic

4,503 followers

BrainCheck, a Nueterra Capital portfolio company that provides a comprehensive cognitive assessment and care platform for patients and practitioners, is marking the announcement of FDA approval for the drug Leqembi® (Eisai US/Biogen) as a “major milestone in the fight against Alzheimer’s disease.” The company issued a statement of their support for the drug in a press release. #cognitivehealth #healthtech https://lnkd.in/gbfYPKGf

BrainCheck Lauds Leqembi FDA Approval, Will Attend Global Alzheimer’s Association Conference

BrainCheck Lauds Leqembi FDA Approval, Will Attend Global Alzheimer’s Association Conference

https://www.nueterra.com

To view or add a comment, sign in

Explore topics